Age and Modified European LeukemiaNet Classification to Predict Transplant Outcomes: An Integrated Approach for Acute Myelogenous Leukemia Patients Undergoing Allogeneic Stem Cell Transplantation.

Item

http://www.wikidata.org/entity/Q35863989

description

2015 nî lūn-bûn

@nan

2015年の論文

@ja

2015年論文

@yue

2015年論文

@zh-hant

2015年論文

@zh-hk

2015年論文

@zh-mo

2015年論文

@zh-tw

2015年论文

@wuu

2015年论文

@zh

2015年论文

@zh-cn

name

Age and Modified European Leuk ...... eic Stem Cell Transplantation.

@ast

Age and Modified European Leuk ...... eic Stem Cell Transplantation.

@en

type

Item

label

Age and Modified European Leuk ...... eic Stem Cell Transplantation.

@ast

Age and Modified European Leuk ...... eic Stem Cell Transplantation.

@en

prefLabel

Age and Modified European Leuk ...... eic Stem Cell Transplantation.

@ast

Age and Modified European Leuk ...... eic Stem Cell Transplantation.

@en

P1476

Age and Modified European Leuk ...... eic Stem Cell Transplantation.

@en

P2093

Antonio M Jimenez

http://www.w3.org/2001/XMLSchema#string

Betül Oran

http://www.w3.org/2001/XMLSchema#string

Borje Andersson

http://www.w3.org/2001/XMLSchema#string

Elizabeth J Shpall

http://www.w3.org/2001/XMLSchema#string

Gabriela Rondon

http://www.w3.org/2001/XMLSchema#string

Issa F Khouri

http://www.w3.org/2001/XMLSchema#string

Julianne Chen

http://www.w3.org/2001/XMLSchema#string

Marcos De Lima

http://www.w3.org/2001/XMLSchema#string

Muzaffar H Qazilbash

http://www.w3.org/2001/XMLSchema#string

Partow Kebriaei

http://www.w3.org/2001/XMLSchema#string

P2860

Hematopoietic cell transplantation (HCT)-specific comorbidity index: a new tool for risk assessment before allogeneic HCT

Karyotypic analysis predicts outcome of preremission and postremission therapy in adult acute myeloid leukemia: a Southwest Oncology Group/Eastern Cooperative Oncology Group Study

Pretreatment cytogenetic abnormalities are predictive of induction success, cumulative incidence of relapse, and overall survival in adult patients with de novo acute myeloid leukemia: results from Cancer and Leukemia Group B (CALGB 8461)

The importance of diagnostic cytogenetics on outcome in AML: analysis of 1,612 patients entered into the MRC AML 10 trial. The Medical Research Council Adult and Children's Leukaemia Working Parties

Diagnosis and management of acute myeloid leukemia in adults: recommendations from an international expert panel, on behalf of the European LeukemiaNet

FLT3 internal tandem duplication associates with adverse outcome and gene- and microRNA-expression signatures in patients 60 years of age or older with primary cytogenetically normal acute myeloid leukemia: a Cancer and Leukemia Group B study

Allogeneic stem cell transplantation for acute myeloid leukemia in first complete remission: systematic review and meta-analysis of prospective clinical trials.

Comparison of reduced-intensity hematopoietic cell transplantation with chemotherapy in patients age 60-70 years with acute myelogenous leukemia in first remission.

Reduced-intensity conditioning regimen workshop: defining the dose spectrum. Report of a workshop convened by the center for international blood and marrow transplant research

Prognostic significance of the European LeukemiaNet standardized system for reporting cytogenetic and molecular alterations in adults with acute myeloid leukemia.

P304

1405-1412

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1016/J.BBMT.2015.03.023

http://www.w3.org/2001/XMLSchema#string

P433

http://www.w3.org/2001/XMLSchema#string

P478

http://www.w3.org/2001/XMLSchema#string

P50

P577

2015-03-31T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

25840338

http://www.w3.org/2001/XMLSchema#string

P932

4506709

http://www.w3.org/2001/XMLSchema#string